Barbagallo_2015_Front.Pharmacol_6_309

Reference

Title : Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes - Barbagallo_2015_Front.Pharmacol_6_309
Author(s) : Barbagallo I , Vanella L , Cambria MT , Tibullo D , Godos J , Guarnaccia L , Zappala A , Galvano F , Li Volti G
Ref : Front Pharmacol , 6 :309 , 2015
Abstract :

Silibinin, a natural plant flavonolignan is the main active constituent found in milk thistle (Silybum marianum). It is known to have hepatoprotective, anti-neoplastic effect, and suppresses lipid accumulation in adipocytes. Objective of this study was to investigate the effect of silibinin on adipogenic differentiation and thermogenic capacity of human adipose tissue derived mesenchymal stem cells. Silibinin (10 muM) treatment, either at the beginning or at the end of adipogenic differentiation, resulted in an increase of SIRT-1, PPARalpha, Pgc-1alpha, and UCPs gene expression. Moreover, silibinin administration resulted in a decrease of PPARgamma, FABP4, FAS, and MEST/PEG1 gene expression during the differentiation, confirming that this compound is able to reduce fatty acid accumulation and adipocyte size. Our data showed that silibinin regulated adipocyte lipid metabolism, inducing thermogenesis and promoting a brown remodeling in adipocyte. Taken together, our findings suggest that silibinin increases UCPs expression by stimulation of SIRT1, PPARalpha, and Pgc-1alpha, improved metabolic parameters, decreased lipid mass leading to the formation of functional adipocytes.

PubMedSearch : Barbagallo_2015_Front.Pharmacol_6_309
PubMedID: 26834634

Related information

Inhibitor Silybin

Citations formats

Barbagallo I, Vanella L, Cambria MT, Tibullo D, Godos J, Guarnaccia L, Zappala A, Galvano F, Li Volti G (2015)
Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes
Front Pharmacol 6 :309

Barbagallo I, Vanella L, Cambria MT, Tibullo D, Godos J, Guarnaccia L, Zappala A, Galvano F, Li Volti G (2015)
Front Pharmacol 6 :309